Market Insight Drug Development |

siRNA Therapies Utilising Lipid Nanoparticles

Kamalinder K Singh

Professor of Pharmaceutical Technology & Drug Delivery

University of Lancashire

12 August, 2026

Watch time: 23 Minutes

Highlights

Takeaways

• Lipid nanoparticles for delivering across biological barriers

• Case study for siRNA delivery for lung inflammation

• Case study for siRNA delivery for crossing blood brain barrier

Kamalinder K Singh, Professor of Pharmaceutical Technology & Drug Delivery, University of Lancashire

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.

Upgrade

Full Video Transcript